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Abstract 
Aim: To compare the efficacy and safety of endoscopic resection (ER) and surgery for the treatment of early gastric 
cancer and precancerous lesions.
Methods: Databases, such as PubMed, EMBASE, Cochrane Library, and Science Citation Index, from 2000 to 2016, 
were searched for eligible articles. In this meta-analysis, the main outcome measurements were local recurrence, com-
plications, metachronous lesions, hospital stay, and 5-year overall survival.
Results: Nine trials were identified and a total of 2748 patients were included. The rate of complication was higher 
in the surgery group compared with the ER group (OR 0.41; 95 % CI 0.30–0.55). The rates of local recurrence and 
metachronous lesions were lower in the surgery group (OR 0.03; 95 % CI 0.00–0.06; OR 8.76; 95 % CI 4.17–18.41). The 
hospital stay was shorter in the ER group (mean difference −6.96; 95 % CI −7.94 to −5.99). The 5-year overall survival 
rate did not significantly differ between the two groups (OR 1.23; 95 % CI 1.03–1.47).
Conclusions: We provided evidence that, ER was comparable to surgery in terms of the 5-year overall survival. In 
addition, ER had a lower rate of complications and shorter hospital stay, but a higher rate of local recurrence and 
metachronous lesions for the treatment of early gastric cancer and precancerous lesions.
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Background
Gastric cancer is the second most common cause of 
cancer-related death in the world, and it remains dif-
ficult to cure, primarily because most patients present 
with advanced disease. Early gastric cancer is defined 
as gastric carcinoma confined to the mucosa and sub-
mucosa of the stomach, with or without regional lymph 
node metastasis (Japanese Gastric Cancer Association 
1998, 2011).
Gastrectomy with lymph node dissection remains 
the standard therapy for early gastric cancer. A variety 
of complications can develop after surgery, and the 
patient’s quality of life can be greatly impacted because 
of the modification of the stomach (Okamura et  al. 
1988).
Endoscopic resection (ER) methods, such as endo-
scopic mucosal resection (EMR) and endoscopic sub-
mucosal dissection (ESD), are widely accepted for the 
treatment of superficial gastric cancer without lymph 
node metastasis, because of the minimal invasion, low 
cost, good patient tolerance, and better quality of life 
after the operation, with low adverse event rates (El-
Sedfy et al. 2014; Shen et al. 2013).
There is no current consensus on the optimal method 
for the treatment of early gastric cancer and precancer-
ous lesions. We conducted a systematic literature review 
to compare the efficacy and safety of ER and surgical 
methods for the treatment of early gastric cancer and 
precancerous lesions.
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Methods
Data sources and searches
We searched databases including PubMed, EMBASE, 
the Cochrane Library, and Science Citation Index from 
January 2000 to March 2016 to identify related articles, 
without language restriction, which compared ER and 
surgery. All bibliographies were indentified in the ref-
erence lists. The search terms were “gastric cancer or 
gastric neoplasia” and “endoscopic mucosal resection 
or endoscopic submucosal dissection”. Major proceed-
ings of international meetings (such as Digestive Dis-
ease Week and Asian Pacific Digestive Week) were also 
hand-searched.
Study selection
The inclusion and exclusion criteria are shown in Table 1.
Data extraction and quality assessment
Data were extracted by one investigator and confirmed by 
the other according to a predefined data extraction form. 
Disagreements were resolved by consultation with a 
third investigator. The following data were collected: year 
of publication, first author, country, duration, age, sex, 
depth of invasion, differentiation and follow up period, 
the local recurrence rate, procedure-related complica-
tions, metachronous lesions, hospital stay, and 5-year 
overall survival. The Newcastle-Ottawa Scale was used to 
assess the quality of the included non-randomized stud-
ies (Wells et al. 2015).
Statistical analysis
All extracted data were entered in the freeware program 
Review Manager (Version 5.0 for Windows, Cochrane 
Collaboration). The weighted mean difference was rec-
ommended for continuous data, and the odds ratio (OR) 
with 95  % confidence intervals (CI) was recommended 
for dichotomous data. Statistical heterogeneity between 
trials was evaluated by the Chi square test and was con-
sidered to be present when P was less than 0.1. We also 
used I2 to assess the heterogeneity. An I2 of more than 
50  % was considered to be statistically significant. In 
the presence of statistical heterogeneity, heterogeneity 
was explored by subgroup analysis or a random-effects 
model. Publication bias was detected by a funnel plot, 
and then the symmetry of the funnel plot was confirmed 
by the Egger’s test, with a P value of 0.05.
Results
Study selection
A total of 2251 potential studies were retrieved for the 
meta-analysis. 1675 were excluded for not including the 
surgical treatment and 565 were excluded because ER 
and surgery were not compared. Of the 11 remaining 
articles, 2 were excluded because they had not compared 
the main outcomes. The remaining 9 eligible studies (Cho 
et al. 2015; Song et al. 2015; Choi et al. 2011, 2015; Kim 
et al. 2014, 2015; Park et al. 2014; Chung et al. 2014; Chiu 
et  al. 2012) were chosen for further analysis (Fig.  1). A 
total of 2748 patients were included in the meta-anal-
ysis, including 1339 patients in the ER group and 1409 
patients in the surgery group. Of these studies, 6 included 
only patients with ESD (Cho et al. 2015; Song et al. 2015; 
Park et al. 2014; Kim et al. 2014; Chung et al. 2014; Chiu 
et  al. 2012), 1 included only patients with EMR (Choi 
et al. 2011), and 2 included patients with both ESD and 
EMR (Choi et al. 2015; Kim et al. 2015). Open surgery or 
laparoscopic surgery were mentioned in 5 studies (Choi 
et al. 2015; Kim et al. 2014, 2015; Chung et al. 2014; Chiu 
Table 1 The inclusion and exclusion criteria of the study
Inclusion criteria Exclusion criteria
Early gastric cancer diagnosis for every patient was 
confirmed by histology
Case report






Guidelines Fig. 1 Flow diagram of trial selection
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et al. 2012), while the other 4 studies did not describe the 
specific operation method (Cho et  al. 2015; Song et  al. 
2015; Park et al. 2014; Choi et al. 2011). All of the studies 
were retrospective case–control studies, not randomized 
controlled trials (RCTs). The key characteristics of the 
studies are listed in Table 2.
Local recurrence
The local recurrence rates were reported in 7 studies 
(Cho et al. 2015; Song et al. 2015; Choi et al. 2011, 2015; 
Park et  al. 2014; Kim et  al. 2014; Chung et  al. 2014). A 
random effect model was applied because of the heter-
ogeneity (P  <  0.00001, I2 =  87  %). The analysis showed 
that the local recurrence rate was higher in the ER group 
(34/1064) than in the surgery group (8/1062) (OR 0.03; 
95 % CI 0.00–0.06) (Fig. 2). When the study from China 
was excluded (Song et al. 2015), heterogeneity still existed 
(P < 0.00001, I2 = 90 %).
Complications
Complications were reported in 8 studies (Cho et  al. 
2015; Song et al. 2015; Choi et al. 2011, 2015; Kim et al. 
2014, 2015; Park et al. 2014; Chiu et al. 2012). There was 
no heterogeneity among the studies (P = 0.12, I2 = 39 %). 
A fixed effect model was applied, and the subsequent 
analysis showed that the rate of complications was lower 
in the ER group (70/1263) than in the surgery group 
(149/1160) (OR 0.41; 95 % CI 0.30–0.55) (Fig. 3).
Metachronous lesions
Metachronous lesions were reported in 6 studies (Cho 
et al. 2015; Kim et al. 2014, 2015; Park et al. 2014; Chung 
et  al. 2014; Choi et  al. 2011). There was no heterogene-
ity in the studies (P = 0.85, I2 = 0 %), and a fixed effect 
model was applied. The rate of metachronous lesions 
was higher in the ER group (58/939) compared with the 
surgery group (8/1181) (OR 8.76; 95  % CI 4.17–18.41) 
(Fig. 4).
Hospital stay
The hospital stay was reported in 3 studies (Cho et  al. 
2015; Song et al. 2015; Kim et al. 2014). There was no het-
erogeneity in the studies (P = 0.95, I2 = 0 %), and a fixed 
effect model was applied. The mean hospital stay was 
significantly shorter in the ER group, compared with the 
surgery group (Mean difference −6.96; 95 % CI −7.94 to 
−5.99) (Fig. 5).
5‑Year overall survival
The 5-year overall survival was reported in 5 studies (Cho 
et al. 2015; Song et al. 2015; Choi et al. 2011, 2015; Kim 
et al. 2015; Park et al. 2014). There was no heterogeneity 
in these studies (P = 0.33, I2 = 13 %), and a fixed effect 
model was applied. Analysis showed that there was no 
significant difference in the 5-year overall survival rate 
between the ER group and the surgery group (OR 1.23; 
95 % CI 1.03–1.47) (Fig. 6).
Publication bias
We used the local recurrence rate as the outcome, and 
no publication bias was detected by funnel plot and the 
Egger’s test (P = 0.862).
Discussion
The comparison between ER and surgery in the treat-
ment of early gastric cancer is still controversial. Even 
though ER is less invasive and less expensive, and could 
better preserve the physiological function of the stom-
ach, additional surgery with lymph node dissection is 
recommended when ER is histologically non-curative 
or submucosal invasion is detected regardless of margin 
status because of possible residual tumors or lymph node 
metastasis (Oda et al. 2008; Song et al. 2008).
Therefore, we designed the meta-analysis to system-
atically evaluate the two techniques, providing evidence 
for the optimal treatment of early gastric cancer. In the 
present analysis, 9 retrospective studies were included, 
and the results confirmed that compared with surgery, 
ER had a higher rate of local recurrence and metachro-
nous lesions for the treatment of early gastric cancer and 
precancerous lesions. Because the ER method preserves 
the whole stomach, the incidence of local recurrence and 
metachronous lesions after ER was higher than after sur-
gery (Nakajima et al. 2006; Takeda et al. 1998; Hosokawa 
et al. 2002). In most cases, local recurrent and metachro-
nous lesions were successfully cured with additional 
endoscopic treatments. That is why there was no signifi-
cant difference in the 5-year overall survival rate between 
the two groups.
The complications of ER included bleeding and perfo-
ration, which can be managed using endoscopic treat-
ment. The complications that occurred after gastrectomy 
included bleeding, duodenal leakage, ileus and hepatic 
dysfunction, and pancreatic leakage. 5 studies provided 
the data of the complication rate for EGC. The pooled 
analysis showed that it was higher in the surgery group 
than the ER group.
Five studies compared the hospital stay between 
the two groups, three studies provided the data of 
mean ± SD, and the mean hospital stay was significantly 
shorter in the ER group, compared with the surgery 
group.
Two studies (Choi et  al. 2011; Kim et  al. 2014) com-
pared the medical cost between the two groups. The 
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results showed that ER patients had lower medical costs 
than patients who had conventional surgeries for early 
gastric cancer. Choi et  al. (2015) reported that endo-
scopic treatment for EGC provides a better quality of life, 
but stomach preservation might provoke cancer recur-
rence worries.
There is an alternative therapeutic approach for the 
treatment of early gastric cancer which combines the 
Fig. 2 The rate of local recurrence comparing ER and surgery
Fig. 3 The rate of complications comparing ER and surgery
Fig. 4 The rate of metachronous lesions comparing ER and surgery
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advantages of both surgical and endoscopic treatment 
also known as laparoscopic endoscopic cooperative 
surgery (LECS) which was introduced in 2009. It was 
reported that LECS held great promise for the future of 
minimally invasive oncologic procedures for the treat-
ment of early gastric cancer (Ntourakis and Mavrogenis 
2015). It can be used as an alternative to endoscopic ther-
apy and surgical treatment.
There were certain limitations in our analysis. First, 
the major limitation of this meta-analysis was that none 
of the included studies were randomized. This certainly 
attenuated the evidence level and value of this meta-anal-
ysis. Second, included studies were from only 2 countries, 
Korea and China, so the results need further confirma-
tion in other countries.
In conclusion, based on the findings of our meta-anal-
ysis, ER showed advantages over surgery for early gastric 
cancer and precancerous lesions regarding the proce-
dure-related complication rate and hospital stay. The dis-
advantages of ER were the higher rate of local recurrence 
and metachronous lesions. Fortunately, we can treat these 
with additional endoscopic treatments without affecting 
overall survival. In the view of the present meta-analysis 
and all available trials, we suggest that ER is appropriate 
to most early gastric cancer and precancerous lesions.
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